CorMedix Company Profile (NYSEMKT:CRMD)

About CorMedix

CorMedix logoCorMedix Inc. is a commercial pharmaceutical and medical device company. The Company in-licenses, develops and commercializes prophylactic and therapeutic products for the prevention and treatment of infectious and inflammatory diseases. The Company has in-licensed the rights to develop and commercialize its product candidate, CRMD003 (Neutrolin), which addresses market opportunities in the instances in which a central venous catheter is used, such as hemodialysis, intensive care units, oncology, and patients receiving total parenteral nutrition, intravenous (IV) hydration, and/or IV medications. Neutrolin is an anti-infective solution for the prevention of catheter-related infections and thrombosis in the central venous catheter markets, such as dialysis, critical care and oncology. Neutrolin is a broad-spectrum antimicrobial/antifungal and anticoagulant combination that is active against common microbes, including antibiotic-resistant strains, and may prevent biofilm formation.

Industry, Sector and Symbol:
  • Sector: Medical
  • Industry: Biotechnology
  • Sub-Industry: N/A
  • Exchange: NYSEMKT
  • Symbol: CRMD
  • CUSIP:
Key Metrics:
  • Previous Close: $2.24
  • 50 Day Moving Average: $1.8862
  • 200 Day Moving Average: $1.9871
  • 52-Week Range: $1.35 - $4.54
  • Trailing P/E Ratio: N/A
  • Foreward P/E Ratio: -4.00
  • P/E Growth: 0.0000
  • Market Cap: $89.64M
  • Outstanding Shares: 40,296,000
  • Beta: 0.24
Additional Links:
Companies Related to CorMedix:

Analyst Ratings

Consensus Ratings for CorMedix (NYSEMKT:CRMD) (?)
Ratings Breakdown: 2 Buy Ratings
Consensus Rating:Buy (Score: 3.00)
Consensus Price Target: $5.75

Analysts' Ratings History for CorMedix (NYSEMKT:CRMD)
Show:
DateFirmActionRatingPrice TargetDetails
11/11/2016FBR & CoLower Price TargetOutperform$6.00 -> $4.00View Rating Details
3/17/2016Rodman & RenshawBoost Price TargetBuy$6.50 -> $7.50View Rating Details
11/16/2015Roth CapitalLower Price TargetNeutral$2.75 -> $2.50View Rating Details
11/12/2015HC WainwrightInitiated CoverageBuy$6.50View Rating Details
(Data available from 2/22/2015 forward)

Earnings

Earnings History for CorMedix (NYSEMKT:CRMD)
DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallDetails
3/14/2017        
5/5/2016Q1($0.09)($0.12)ViewN/AView Earnings Details
3/16/2015($0.12)($0.09)ViewN/AView Earnings Details
11/17/2014($0.09)($0.09)ViewN/AView Earnings Details
8/20/2014($0.13)($0.26)ViewN/AView Earnings Details
(Data available from 1/1/2011 forward)

Estimates

Earnings Estimates for CorMedix (NYSEMKT:CRMD)
Current Year EPS Consensus Estimate: $-0.71 EPS
Next Year EPS Consensus Estimate: $-0.56 EPS

Dividends

Dividend History for CorMedix (NYSEMKT:CRMD)
No dividend announcements for this company have been tracked by MarketBeat.com

Insider Trades

Insider Trading History for CorMedix (NYSEMKT:CRMD)
Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
2/7/2017Antony PfaffleInsiderSell10,000$2.00$20,000.00View SEC Filing  
1/30/2017Cora M TellezDirectorBuy1,780$1.79$3,186.20View SEC Filing  
12/30/2016Cora M TellezDirectorBuy1,990$1.58$3,144.20View SEC Filing  
12/9/2016Khoso BaluchCEOBuy10,000$1.77$17,700.00View SEC Filing  
11/30/2016Cora M TellezDirectorBuy1,800$1.80$3,240.00View SEC Filing  
10/31/2016Cora M TellezDirectorBuy1,475$2.15$3,171.25View SEC Filing  
10/21/2016Antony PfaffleInsiderSell20,000$2.23$44,600.00View SEC Filing  
9/22/2016Janet DillioneDirectorBuy15,000$2.66$39,900.00View SEC Filing  
8/25/2016Taunia MarkvickaDirectorBuy18,600$1.65$30,690.00View SEC Filing  
8/19/2016Cora M TellezDirectorBuy12,500$1.73$21,625.00View SEC Filing  
6/21/2016Antony PfaffleInsiderSell29,657$2.14$63,465.98View SEC Filing  
6/20/2016Antony PfaffleInsiderSell10,000$2.16$21,600.00View SEC Filing  
6/15/2016Antony PfaffleInsiderSell4,900$2.21$10,829.00View SEC Filing  
6/13/2016Antony PfaffleInsiderSell5,443$2.27$12,355.61View SEC Filing  
6/9/2016Antony PfaffleInsiderSell10,000$2.38$23,800.00View SEC Filing  
6/8/2016Janet DillioneDirectorBuy3,738$2.67$9,980.46View SEC Filing  
6/3/2016Matthew DuffyDirectorSell46,106$2.73$125,869.38View SEC Filing  
5/31/2016Steven W LefkowitzDirectorSell50,000$2.88$144,000.00View SEC Filing  
5/25/2016Cora M TellezDirectorBuy8,600$2.90$24,940.00View SEC Filing  
5/24/2016Antony PfaffleInsiderSell12,700$2.73$34,671.00View SEC Filing  
5/24/2016Antony PfaffleInsiderSell12,700$2.73$34,671.00View SEC Filing  
5/23/2016Antony PfaffleInsiderSell15,000$2.89$43,350.00View SEC Filing  
5/23/2016Steven W LefkowitzDirectorSell30,000$2.93$87,900.00View SEC Filing  
5/19/2016Antony PfaffleInsiderSell12,300$2.82$34,686.00View SEC Filing  
5/16/2016Antony PfaffleInsiderSell60,000$2.68$160,800.00View SEC Filing  
6/30/2015Randy MilbyCEOBuy1,610$3.88$6,246.80View SEC Filing  
6/23/2015Taunia MarkvickaDirectorBuy4,000$4.81$19,240.00View SEC Filing  
6/15/2015Randy MilbyCEOBuy1,245$5.02$6,249.90View SEC Filing  
6/4/2015Matthew DuffyDirectorSell30,000$6.48$194,400.00View SEC Filing  
5/29/2015Randy MilbyCEOBuy1,026$6.09$6,248.34View SEC Filing  
2/27/2015Randy MilbyCEOBuy1,211$5.16$6,248.76View SEC Filing  
2/13/2015Randy MilbyCEOBuy1,911$3.27$6,248.97View SEC Filing  
1/30/2015Randy MilbyCEOBuy2,016$3.10$6,249.60View SEC Filing  
12/15/2014Randy MilbyCEOBuy4,734$1.32$6,248.88View SEC Filing  
11/28/2014Randy MilbyCEOBuy4,464$1.40$6,249.60View SEC Filing  
11/14/2014Cora M TellezDirectorBuy11,086$1.52$16,850.72View SEC Filing  
11/14/2014Randy MilbyCEOBuy4,111$1.52$6,248.72View SEC Filing  
10/31/2014Randy MilbyCEOBuy3,434$1.82$6,249.88View SEC Filing  
9/30/2014Randy MilbyCEOBuy3,324$1.88$6,249.12View SEC Filing  
9/15/2014Randy MilbyCEOBuy3,654$1.71$6,248.34View SEC Filing  
8/29/2014Randy MilbyCEOBuy3,125$2.00$6,250.00View SEC Filing  
8/15/2014Randy MilbyCEOBuy3,140$1.99$6,248.60View SEC Filing  
7/31/2014Randy MilbyCEOBuy6,250$2.00$12,500.00View SEC Filing  
6/30/2014Randy MilbyCEOBuy2,732$1.83$4,999.56View SEC Filing  
12/13/2013Steven W LefkowitzInsiderBuy18,000$0.78$14,040.00View SEC Filing  
(Data available from 1/1/2013 forward)

Headlines

Latest Headlines for CorMedix (NYSEMKT:CRMD)
DateHeadline
News IconCorMedix Inc CRMD Financial and Strategic SWOT Analysis Review [Updated: 13012017] Prices from USD $300 (NYSEMKT:CRMD)
www.bioportfolio.com - February 18 at 10:57 AM
News IconStock Levels in Review for CorMedix Inc. (CRMD) - Baxter Review (NYSEMKT:CRMD)
baxternewsreview.com - February 16 at 4:35 PM
News IconShares Making an Appearance on Today's Most Volatile List: CorMedix, Inc. (:CRMD) - Aiken Advocate (NYSEMKT:CRMD)
aikenadvocate.com - February 16 at 4:35 PM
News IconTrading Radar: Checking Technicals for CorMedix Inc. (CRMD) - Rives Journal (NYSEMKT:CRMD)
rivesjournal.com - February 15 at 3:25 AM
News IconChecking the Chart on Shares of CorMedix Inc. (CRMD) - Davidson Register (NYSEMKT:CRMD)
davidsonregister.com - February 10 at 9:53 PM
News IconChief Scientific Officer of CorMedix Inc (NYSEMKT:CRMD), Pfaffle Antony, sells 10,000 shares worth $20,000 (NYSEMKT:CRMD)
empowerednews.net - February 9 at 2:57 AM
News IconStock Radar: Viewing Levels for CorMedix Inc. (CRMD) - Piedmont Register (NYSEMKT:CRMD)
piedmontregister.com - February 8 at 4:52 PM
News IconErratic Volume Stretches This Stock Mid-Session: CorMedix, Inc. (:CRMD) - Davidson Register (NYSEMKT:CRMD)
davidsonregister.com - February 6 at 4:34 PM
News IconTechnical Toolbox: Investor Focus on CorMedix Inc. (CRMD) - Sherwood Daily (NYSEMKT:CRMD)
sherwooddaily.com - February 3 at 4:47 PM
News IconStock Trickling Lower Heading Into The Open: CorMedix, Inc. (:CRMD) - Aiken Advocate (NYSEMKT:CRMD)
aikenadvocate.com - February 3 at 4:47 PM
finance.yahoo.com logoCorMedix Inc. Announces New Appointments to Senior Leadership Team - Yahoo Finance (NYSEMKT:CRMD)
finance.yahoo.com - February 2 at 4:53 PM
News IconTechnical Trading: Focus on Shares of CorMedix Inc. (CRMD) - Sherwood Daily (NYSEMKT:CRMD)
sherwooddaily.com - February 2 at 4:52 PM
us.rd.yahoo.com logoCorMedix Inc. Announces New Appointments to Senior Leadership Team (NYSEMKT:CRMD)
us.rd.yahoo.com - February 1 at 4:51 PM
us.rd.yahoo.com logo8:45 am Cormedix names Robert W. Cook as CFO and Judith R. Abrams, MD., FRCPC as Chief Medical Officer (NYSEMKT:CRMD)
us.rd.yahoo.com - February 1 at 4:51 PM
News IconInvestor Focus on Technical Levels for CorMedix Inc. (CRMD) - Sherwood Daily (NYSEMKT:CRMD)
sherwooddaily.com - January 30 at 5:24 PM
News IconIs This Stock Capable of a Bull Run: CorMedix, Inc. (:CRMD) - Nelson Research (NYSEMKT:CRMD)
nelsonobserver.com - January 30 at 5:24 PM
News IconCheap Stock Alert on CorMedix, Inc. (:CRMD) - Prospect Journal (NYSEMKT:CRMD)
prospectjournal.com - January 30 at 5:24 PM
News IconHigh Volatility Moving the Needle For Shares of CorMedix, Inc. (:CRMD) - Wall Street Beacon (NYSEMKT:CRMD)
wsbeacon.com - January 30 at 5:24 PM
News IconCorMedix Inc CRMD Pharmaceuticals Healthcare Deals and Alliances Profile Prices from USD $250 (NYSEMKT:CRMD)
www.bioportfolio.com - January 29 at 4:36 PM
News IconRipe for A Big Move? Update on CorMedix, Inc. (:CRMD) - Prospect Journal (NYSEMKT:CRMD)
prospectjournal.com - January 27 at 10:59 PM
News IconLooking at the Gauges on CorMedix Inc. (CRMD) - Sherwood Daily (NYSEMKT:CRMD)
sherwooddaily.com - January 27 at 5:58 PM
News IconWatching the Numbers for CorMedix, Inc. (AMEX:CRMD) - The Tribune (NYSEMKT:CRMD)
lakecitytribune.com - January 26 at 5:38 PM
News IconStock Spotter: Review on Technical Levels for CorMedix Inc. (CRMD) - Sherwood Daily (NYSEMKT:CRMD)
sherwooddaily.com - January 26 at 5:38 PM
News IconTrading Corner: Eye on Technical Levels for CorMedix Inc. (CRMD) - Sherwood Daily (NYSEMKT:CRMD)
sherwooddaily.com - January 25 at 10:42 PM
News IconTrading Radar: Checking Technicals for CorMedix Inc. (CRMD) - Sherwood Daily (NYSEMKT:CRMD)
sherwooddaily.com - January 23 at 4:51 PM
News IconInvestors are Looking at Levels for CorMedix Inc. (CRMD) - Sherwood Daily (NYSEMKT:CRMD)
sherwooddaily.com - January 21 at 3:44 AM
News IconIndicator Level Review for CorMedix Inc. (CRMD) - Sherwood Daily (NYSEMKT:CRMD)
sherwooddaily.com - January 20 at 3:48 AM
News IconAmplified Volatility Spotted in Shares of CorMedix, Inc. (:CRMD) - Wall Street Beacon (NYSEMKT:CRMD)
wsbeacon.com - January 20 at 3:48 AM
capitalcube.com logoETFs with exposure to CorMedix, Inc. : January 19, 2017 (NYSEMKT:CRMD)
www.capitalcube.com - January 19 at 5:46 PM
News IconCurious Investors Should Take a Look at This Small Cap Stock: CorMedix, Inc. (:CRMD) - Prospect Journal (NYSEMKT:CRMD)
prospectjournal.com - January 18 at 9:50 PM
News IconShare Focus: Checking the Indicators on CorMedix Inc. (CRMD) - Sherwood Daily (NYSEMKT:CRMD)
sherwooddaily.com - January 18 at 4:50 PM
News IconCorMedix Inc (CRMD) Under Analyst Spotlight - UK Market News (NYSEMKT:CRMD)
www.ukmarketnews.co.uk - January 18 at 4:50 PM
News IconTechnical Analysis: Is Selling Stock Like CorMedix Inc. After This Bearish Multiple Bottom Chart Pattern Winning ... - The Herald Beacon (NYSEMKT:CRMD)
heraldbeacon.com - January 18 at 4:50 PM
finance.yahoo.com logoIs the Options Market Predicting a Spike in CorMedix (CRMD) Stock? (NYSEMKT:CRMD)
finance.yahoo.com - January 18 at 4:50 PM
News IconTop Rated Stock With Earnings Growth & Implied Upside: CorMedix, Inc. (:CRMD) - Prospect Journal (NYSEMKT:CRMD)
prospectjournal.com - January 17 at 8:48 AM
News IconTracking Corporate Insiders: What Are They Doing With CorMedix, Inc. (:CRMD) - Wall Street Beacon (NYSEMKT:CRMD)
wsbeacon.com - January 17 at 8:48 AM
News IconHeady Investors are Taking a Look at CorMedix, Inc. (:CRMD) - Prospect Journal (NYSEMKT:CRMD)
prospectjournal.com - January 12 at 4:51 PM
News IconIs this Stock Under $5 a Bargain: CorMedix, Inc. (:CRMD) - Prospect Journal (NYSEMKT:CRMD)
prospectjournal.com - January 12 at 2:56 AM
News IconIs There Any Upside to This Stock Under $5: CorMedix, Inc. (:CRMD) - Prospect Journal (NYSEMKT:CRMD)
prospectjournal.com - January 9 at 5:38 PM
finance.yahoo.com logoCorMedix Inc. Announces Dismissal of Shareholder Derivative Action Lawsuit and Stipulation to Forego Appeal (NYSEMKT:CRMD)
finance.yahoo.com - January 9 at 5:38 PM
News IconReviewing Individual Broker Targets Of EP Energy Corp (NYSE:EPE) (NYSEMKT:CRMD)
twnewsjp.com - January 5 at 5:04 PM
finance.yahoo.com logoCorMedix to Present at Biotech Showcase 2017 (NYSEMKT:CRMD)
finance.yahoo.com - January 5 at 5:04 PM
News IconNear-Term, Can This Stock Move the Needle: CorMedix, Inc. (:CRMD) - Prospect Journal (NYSEMKT:CRMD)
prospectjournal.com - January 4 at 5:35 PM
News IconUnder the Microscope We Place Shares of CorMedix, Inc. (:CRMD) - Prospect Journal (NYSEMKT:CRMD)
prospectjournal.com - January 4 at 6:58 AM
News IconValue Score Review for CorMedix, Inc. (AMEX:CRMD) - Wall Street Beacon (NYSEMKT:CRMD)
wsbeacon.com - January 3 at 5:28 PM
News IconCheap Stock Alert & Update on CorMedix, Inc. (:CRMD) - Prospect Journal (NYSEMKT:CRMD)
prospectjournal.com - December 30 at 9:55 PM
News IconStreetwise Investors Taking Note of CorMedix, Inc. (:CRMD) - Prospect Journal (NYSEMKT:CRMD)
prospectjournal.com - December 23 at 2:44 AM
News IconKeen Investors Taking a Look at CorMedix, Inc. (:CRMD) - Prospect Journal (NYSEMKT:CRMD)
prospectjournal.com - December 21 at 5:16 PM
News IconInvestors Keen on a Bargain are Looking at CorMedix, Inc. (:CRMD) - Prospect Journal (NYSEMKT:CRMD)
prospectjournal.com - December 21 at 5:16 PM
News IconMarket Spotlight: Focusing on Shares of CorMedix, Inc. (AMEX:CRMD) - Liberty News (NYSEMKT:CRMD)
libertynewsrecord.com - December 21 at 5:16 PM

Social

What is CorMedix's stock symbol?

CorMedix trades on the New York Stock Exchange (NYSE)MKT under the ticker symbol "CRMD."

Where is CorMedix's stock going? Where will CorMedix's stock price be in 2017?

2 brokerages have issued 12 month price objectives for CorMedix's stock. Their forecasts range from $4.00 to $7.50. On average, they anticipate CorMedix's stock price to reach $5.75 in the next year.

When will CorMedix announce their earnings?

CorMedix is scheduled to release their next quarterly earnings announcement on Tuesday, March, 14th 2017.

Who owns CorMedix stock?

CorMedix's stock is owned by many different of retail and institutional investors. Top institutional shareholders include Private Advisor Group LLC (0.24%) and Franklin Resources Inc. (0.19%). Company insiders that own CorMedix stock include Antony Pfaffle, Cora M Tellez, Janet Dillione, Khoso Baluch, Matthew Duffy, Randy Milby, Steven W Lefkowitz and Taunia Markvicka.

Who sold CorMedix stock? Who is selling CorMedix stock?

CorMedix's stock was sold by a variety of institutional investors in the last quarter, including Private Advisor Group LLC. Company insiders that have sold CorMedix stock in the last year include Antony Pfaffle, Matthew Duffy and Steven W Lefkowitz.

Who bought CorMedix stock? Who is buying CorMedix stock?

CorMedix's stock was bought by a variety of institutional investors in the last quarter, including Franklin Resources Inc.. Company insiders that have bought CorMedix stock in the last two years include Cora M Tellez, Janet Dillione, Khoso Baluch, Randy Milby and Taunia Markvicka.

How do I buy CorMedix stock?

Shares of CorMedix can be purchased through any online brokerage account. Popular online brokerages include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

How much does a share of CorMedix stock cost?

One share of CorMedix stock can currently be purchased for approximately $2.24.


Last Updated on 2/22/2017 by MarketBeat.com Staff